Actualités Fortress Biotech Inc - FBIO | Actions NASDAQ

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

Poster Presented on Dermal and Systemic Pharmacokinetics of Oral DFD-29 (Minocycline Hydrochloride Modified...

Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds

WORCESTER, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq:...

Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit

MIAMI, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the...

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

SCOTTSDALE, Ariz., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the...

Fortress Biotech to Participate in October 2024 Investor Conferences

MIAMI, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative...

Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements

MIAMI, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an...

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

SCOTTSDALE, Ariz., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the...

Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference

MIAMI, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative...

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

SCOTTSDALE, Ariz., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the...

Avenue Therapeutics to Participate in Upcoming Investor Conferences

MIAMI, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the...

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

PDUFA goal date of November 4, 2024 for DFD-29 for the treatment of inflammatory lesions and erythema of...

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

New Drug Application for DFD-29 to treat rosacea under FDA review; PDUFA goal date of November 4, 2024 Total...

Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

- Last patient visit complete in Phase 1b/2a clinical trial of AJ201 for spinal and bulbar muscular atrophy;...

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024

SCOTTSDALE, Ariz., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the...

Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027

MIAMI, July 25, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”, or the...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Fortress Biotech Inc (FBIO)

Votre Hub pour des idées et discussions en direct en temps réel

FBIO Actualités

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds

Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Fortress Biotech to Participate in October 2024 Investor Conferences

Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Avenue Therapeutics to Participate in Upcoming Investor Conferences

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024

Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Fortress Biotech Inc (FBIO) Actualités

Fortress Biotech Inc (FBIO)

Votre Hub pour des idées et discussions en direct en temps réel

FBIO Actualités

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds

Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Fortress Biotech to Participate in October 2024 Investor Conferences

Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Avenue Therapeutics to Participate in Upcoming Investor Conferences

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024

Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités